Tag: H.C. Wainwright

  • This is Why Cassava Sciences (SAVA) Could Explode — Again

    This is Why Cassava Sciences (SAVA) Could Explode — Again

    Cassava Sciences (SAVA) is soaring again. After pulling back to strong support around $91, the stock is back to $108 thanks to new price targets, and progress on its lead drug candidate for Alzheimer’s. H.C. Wainwright raised its price target to $124 on SAVA.  Cantor Fitzgerald raised its target to $100.  Better, the company already…